Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)

NCT04494191 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Flibanserin 100Mg Tab
DRUG: Flibanserin 100 MG [Addyi]

Sponsor

Genuine Research Center, Egypt

Collaborators

[object Object]